Nagler David

CIK 00014161752 companiesFREMONT, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001416175

Recent Transactions

17 trades

Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-06-20$2.19/sh+300→ 300 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-06-20−5,000→ 32,347 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-06-20$2.19/sh+4,700→ 4,700 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-06-20$46.02/sh−300→ 0 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-06-20$45.25/sh−4,700→ 0 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-11-16+50,000→ 50,000 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-09-27−3,750→ 37,347 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2017-09-27$30.00/sh−3,750→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2017-09-27$2.19/sh+3,750→ 3,750 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-09-15−3,750→ 41,097 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2017-09-15$25.00/sh−3,750→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2017-09-15$2.19/sh+3,750→ 3,750 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-01-25+50,000→ 50,000 total
Award
ARYx Therapeutics, Inc.
Restricted Stock Units
2010-02-25+130,000→ 130,000 total
Gift
ARYx Therapeutics, Inc.
Common Stock
2009-12-21+1,000→ 1,000 total
Gift
ARYx Therapeutics, Inc.
Common Stock
2009-12-21−1,250→ 1,837 total
Award
ARYx Therapeutics, Inc.
Stock Option (Right to Buy)
2009-02-18+60,000→ 60,000 total

Companies

Recent Filings

Address

C/O ARYX THERAPEUTICS, INC. 6300 DUMBARTON CIRCLE

FREMONT, CA, 94555

View on SEC.gov